Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach

Detalhes bibliográficos
Autor(a) principal: Rodrigues, F.
Data de Publicação: 2014
Outros Autores: Pereira, C., Pimentel, F. B., Alves, R. C., Ferreira, M., Sarmento, B., Amaral, Maria Helena, Beatriz, M., Oliveira, P. P.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.22/7269
Resumo: Recent changes in regulatory requirements and social views on animal testing have incremented the development of reliable alternative tests for predicting skin and ocular irritation potential of products based on new raw materials. In this regard, botanical ingredients used in cosmetic products are among those materials, and should be carefully reviewed concerning the potential presence of irritant constituents. In particular, cosmetic products used on the face, in vicinity of the eyes or that may come in contact with mucous membranes, should avoid botanical ingredients that contain, or are suspected to contain, such ingredients. In this study, we aimed to evaluate the effect of a new cosmetic ingredient, namely, coffee silverskin (CS), with an in vitro skin and ocular irritation assay using reconstructed human epidermis, EpiSkin™, and human corneal epithelial model, SkinEthics™ HCE, and an in vivo assay. Three different extracts of CS were evaluated. The histology of the models after extracts applications was analysed. The in vitro results demonstrated that extracts were not classified as irritant and the histological analyses proved that extracts did not affect both models structure. The content of caffeine, 5-hydroxymethyl furfural and chlorogenic acid was quantified after the epidermal assay. The in vivo test carried out with the most promising extract (hydroalcoholic) showed that, with respect to irritant effects, these extracts can be regarded as safe for topical application.
id RCAP_a31c13c275ce03d5b90dc409a052e07c
oai_identifier_str oai:recipp.ipp.pt:10400.22/7269
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approachIn vitro skin culturesInterleukin-1α (IL-1α)Skin irritation potentialCoffee silverskinEpiSkinSkinEthicsRecent changes in regulatory requirements and social views on animal testing have incremented the development of reliable alternative tests for predicting skin and ocular irritation potential of products based on new raw materials. In this regard, botanical ingredients used in cosmetic products are among those materials, and should be carefully reviewed concerning the potential presence of irritant constituents. In particular, cosmetic products used on the face, in vicinity of the eyes or that may come in contact with mucous membranes, should avoid botanical ingredients that contain, or are suspected to contain, such ingredients. In this study, we aimed to evaluate the effect of a new cosmetic ingredient, namely, coffee silverskin (CS), with an in vitro skin and ocular irritation assay using reconstructed human epidermis, EpiSkin™, and human corneal epithelial model, SkinEthics™ HCE, and an in vivo assay. Three different extracts of CS were evaluated. The histology of the models after extracts applications was analysed. The in vitro results demonstrated that extracts were not classified as irritant and the histological analyses proved that extracts did not affect both models structure. The content of caffeine, 5-hydroxymethyl furfural and chlorogenic acid was quantified after the epidermal assay. The in vivo test carried out with the most promising extract (hydroalcoholic) showed that, with respect to irritant effects, these extracts can be regarded as safe for topical application.ElsevierRepositório Científico do Instituto Politécnico do PortoRodrigues, F.Pereira, C.Pimentel, F. B.Alves, R. C.Ferreira, M.Sarmento, B.Amaral, Maria HelenaBeatriz, M.Oliveira, P. P.2015-12-28T15:45:53Z2014-012014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.22/7269eng10.1016/j.indcrop.2014.10.014info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-13T12:47:37Zoai:recipp.ipp.pt:10400.22/7269Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:27:44.425710Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
title Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
spellingShingle Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
Rodrigues, F.
In vitro skin cultures
Interleukin-1α (IL-1α)
Skin irritation potential
Coffee silverskin
EpiSkin
SkinEthics
title_short Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
title_full Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
title_fullStr Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
title_full_unstemmed Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
title_sort Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
author Rodrigues, F.
author_facet Rodrigues, F.
Pereira, C.
Pimentel, F. B.
Alves, R. C.
Ferreira, M.
Sarmento, B.
Amaral, Maria Helena
Beatriz, M.
Oliveira, P. P.
author_role author
author2 Pereira, C.
Pimentel, F. B.
Alves, R. C.
Ferreira, M.
Sarmento, B.
Amaral, Maria Helena
Beatriz, M.
Oliveira, P. P.
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico do Porto
dc.contributor.author.fl_str_mv Rodrigues, F.
Pereira, C.
Pimentel, F. B.
Alves, R. C.
Ferreira, M.
Sarmento, B.
Amaral, Maria Helena
Beatriz, M.
Oliveira, P. P.
dc.subject.por.fl_str_mv In vitro skin cultures
Interleukin-1α (IL-1α)
Skin irritation potential
Coffee silverskin
EpiSkin
SkinEthics
topic In vitro skin cultures
Interleukin-1α (IL-1α)
Skin irritation potential
Coffee silverskin
EpiSkin
SkinEthics
description Recent changes in regulatory requirements and social views on animal testing have incremented the development of reliable alternative tests for predicting skin and ocular irritation potential of products based on new raw materials. In this regard, botanical ingredients used in cosmetic products are among those materials, and should be carefully reviewed concerning the potential presence of irritant constituents. In particular, cosmetic products used on the face, in vicinity of the eyes or that may come in contact with mucous membranes, should avoid botanical ingredients that contain, or are suspected to contain, such ingredients. In this study, we aimed to evaluate the effect of a new cosmetic ingredient, namely, coffee silverskin (CS), with an in vitro skin and ocular irritation assay using reconstructed human epidermis, EpiSkin™, and human corneal epithelial model, SkinEthics™ HCE, and an in vivo assay. Three different extracts of CS were evaluated. The histology of the models after extracts applications was analysed. The in vitro results demonstrated that extracts were not classified as irritant and the histological analyses proved that extracts did not affect both models structure. The content of caffeine, 5-hydroxymethyl furfural and chlorogenic acid was quantified after the epidermal assay. The in vivo test carried out with the most promising extract (hydroalcoholic) showed that, with respect to irritant effects, these extracts can be regarded as safe for topical application.
publishDate 2014
dc.date.none.fl_str_mv 2014-01
2014-01-01T00:00:00Z
2015-12-28T15:45:53Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.22/7269
url http://hdl.handle.net/10400.22/7269
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.indcrop.2014.10.014
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131372487442432